| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other comprehensive (loss) income, net of tax | -5,782 | 18,968 | 11,068 | - |
| Total comprehensive loss | -84,900 | -28,949 | -59,093 | -55,084 |
| Basic net loss per ordinary share (in usd per share) | -0.3 | -0.18 | -0.26 | -0.31 |
| Diluted net loss per ordinary share (in usd per share) | -0.3 | -0.18 | -0.26 | -0.31 |
| Weighted-average basic ordinary shares (in shares) | 266,141,431 | 266,141,411 | 266,126,548 | 266,084,589 |
| Weighted-average diluted ordinary shares (in shares) | 266,141,431 | 266,141,411 | 266,126,548 | 266,084,589 |
Autolus Therapeutics plc (AUTL)
Autolus Therapeutics plc (AUTL)